Search results

ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.

In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth.

Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

Since the discovery of superconducting Caintercalated graphite (CaC6) the intercalation of epitaxial graphene on SiC(0001) with Ca has been studied extensively in order to achieve superconductivity.

Applications are now being accepted for the Industry foundations Scholarship.

Within the bulk structure of such glasses, boron is known to be a key actor, as it exhibits intriguing and composition-dependent changes in coordination state that often drive properties.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

Aimed at the delegated Radiation Safety Officer responsible for radioactive substances and/or radiation apparatus. This course is well suited to those working in research or medical industries

The physics and chemistry used at ANSTO is built upon, in significant part, by pioneering female scientists who were sidelined, expelled, or simply not credited appropriately for their achievements.

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

ANSTO’s Centre for Accelerator Science has been selected as a partner facility in RADNEXT 2030, a major European initiative that provides researchers and industry with access to radiation testing infrastructure for electronics.

In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.

Project members of Magnetism.